Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats

Addiction Biology

Volumn 17, Issue 2, 2012, Pages 300-308

  Zorrilla, Eric P ^a,b   Wee, Sunmee ^a   Zhao, Yu ^a,b,c   Specio, Sheila ^a   Boutrel, Benjamin ^a,d   Koob, George F ^a   Weiss, Friedbert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Harold L Dorris Neurological Research Institute   (United States)

^c AMYLIN PHARMACEUTICALS INC   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Amygdala; cocaine addiction or dependence; CRF or CRH or corticotropin releasing factor or corticotropin releasing hormone; neuropeptide; operant intravenous drug self administration; stress

Indexed keywords

COCAINE; CORTICOTROPIN RELEASING FACTOR;

ADAPTATION; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOLATERAL AMYGDALA; CENTRAL NUCLEUS (AMYGDALA); COCAINE DEPENDENCE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

AMYGDALA; ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; CORTICOTROPIN-RELEASING HORMONE; EXTINCTION, PSYCHOLOGICAL; MALE; RATS; RATS, WISTAR; SELF ADMINISTRATION; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84857649055     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00329.x     Document Type: Article

References (61)

1. Ahmed SH, Kenny PJ, Koob GF, Markou A, (2002) Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci 5: 625-626. (Pubitemid 34742974)
2. Ahmed SH, Koob GF, (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300. (Pubitemid 28487203)
3. Ahmed SH, Koob GF, (1999) Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology (Berl) 146: 303-312. (Pubitemid 29480242)
4. Ambrosio E, Sharpe LG, Pilotte NS, (1997) Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse 25: 272-276. (Pubitemid 27123028)
5. Aubry JM, Pozzoli G, Vale WW, (1999) Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala. Neurosci Lett 266: 197-200. (Pubitemid 29249249)
6. Austin MC, Rhodes JL, Lewis DA, (1997) Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem. Neuropsychopharmacology 17: 326-341. (Pubitemid 27468170)
7. Basso AM, Spina M, Rivier J, Vale W, Koob GF, (1999) Corticotropin- releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) 145: 21-30. (Pubitemid 29339759)
8. Brown ZJ, Tribe E, D'Souza NA, Erb S, (2009) Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 203: 121-130.
9. Caine SB, Lintz R, Koob GF, (1993) Intravenous drug self-administration techniques in animals. In:, Sahgal A, ed. Behavioural Neuroscience: A Practical Approach, vol 2. pp. 117-143. Oxford: IRL Press.
10. Chalmers DT, Lovenberg TW, De Souza EB, (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340-6350.
11. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB, (1986) Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6: 2908-2914. (Pubitemid 16026071)
12. Cummings S, Elde R, Ells J, Lindall A, (1983) Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3: 1355-1368. (Pubitemid 13016165)
13. Erb S, Funk D, Borkowski S, Watson SJ, Akil H, (2004) Effects of chronic cocaine exposure on corticotropin-releasing hormone binding protein in the central nucleus of the amygdala and bed nucleus of the stria terminalis. Neuroscience 123: 1003-1009. (Pubitemid 38130108)
14. Erb S, Funk D, Le AD, (2003) Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin- releasing factor (CRF) in rats. Psychopharmacology (Berl) 170: 383-389. (Pubitemid 38010510)
15. Erb S, Funk D, Le AD, (2005) Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity. Neurosci Lett 383: 209-214. (Pubitemid 40805557)
16. Erb S, Kayyali H, Romero K, (2006a) A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor. Pharmacol Biochem Behav 85: 206-213. (Pubitemid 44772922)
17. Erb S, Petrovic A, Yi D, Kayyali H, (2006b) Central injections of CRF reinstate cocaine seeking in rats after postinjection delays of up to 3 h: an influence of time and environmental context. Psychopharmacology (Berl) 187: 112-120. (Pubitemid 43876923)
18. Fu Y, Pollandt S, Liu J, Krishnan B, Genzer K, Orozco-Cabal L, Gallagher JP, Shinnick-Gallagher P, (2007) Long-term potentiation (LTP) in the central amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptors. J Neurophysiol 97: 937-941. (Pubitemid 46143409)
19. Gawin FH, Ellinwood EH Jr, (1989) Cocaine dependence. Annu Rev Med 40: 149-161. (Pubitemid 19145348)
20. Gawin FH, Kleber HD, (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 43: 107-113. (Pubitemid 16163529)
21. Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ, (2003) The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. J Pharmacol Exp Ther 305: 434-439. (Pubitemid 36459155)
22. Gingrich JA, Hen R, (2001) Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 155: 1-10. (Pubitemid 32295763)
23. Goeders NE, Guerin GF, (2000) Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats. Neuropsychopharmacology 23: 577-586.
24. Gurkovskaya O, Goeders NE, (2001) Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats. Eur J Pharmacol 432: 53-56. (Pubitemid 33153132)
25. Kampman KM, Volpicelli JR, McGinnis DE, Alterman AI, Weinrieb RM, D'Angelo L, Epperson LE, (1998) Reliability and validity of the Cocaine Selective Severity Assessment. Addict Behav 23: 449-461. (Pubitemid 28311333)
26. Kasarabada ND, Anglin MD, Khalsa-Denison E, Paredes A, (1998) Variations in psychosocial functioning associated with patterns of progression in cocaine-dependent men. Addict Behav 23: 179-189. (Pubitemid 28136007)
27. Kirby LG, Rice KC, Valentino RJ, (2000) Effects of corticotropin- releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22: 148-162. (Pubitemid 30016017)
28. Koob GF, (2008) A role for brain stress systems in addiction. Neuron 59: 11-34. (Pubitemid 351905857)
29. Levin JR, Serlin RC, Seaman MA, (1994) A controlled, powerful multiple-comparison strategy for several situations. Psychol Bull 115: 153-159. (Pubitemid 24976741)
30. Lowry CA, Rodda JE, Lightman SL, Ingram CD, (2000) Corticotropin- releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 20: 7728-7736.
31. Lu L, Liu D, Ceng X, (2001) Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur J Pharmacol 415: 203-208. (Pubitemid 32239465)
32. Lu L, Liu Z, Huang M, Zhang Z, (2003) Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J Neurochem 84: 1378-1386. (Pubitemid 36343604)
33. Maj M, Turchan J, Smialowska M, Przewlocka B, (2003) Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides 37: 105-110. (Pubitemid 37421493)
34. Mantsch JR, Baker DA, Francis DM, Katz ES, Hoks MA, Serge JP, (2008) Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psychopharmacology (Berl) 195: 591-603. (Pubitemid 350160496)
35. Merchenthaler I, (1984) Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 5 (Suppl 1): 53-69. (Pubitemid 14120673)
36. Palkovits M, Brownstein MJ, Vale W, (1985) Distribution of corticotropin-releasing factor in rat brain. Fed Proc 44: 215-219. (Pubitemid 15170677)
37. Paterson NE, Markou A, (2003) Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14: 2229-2232.
38. Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, Gallagher JP, Shinnick-Gallagher P, (2006) Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur J Neurosci 24: 1733-1743. (Pubitemid 44427542)
39. Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I, (1998) Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18: 492-502. (Pubitemid 28202356)
40. Price ML, Lucki I, (2001) Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21: 2833-2841. (Pubitemid 32298224)
41. Przegalinski E, Filip M, Frankowska M, Zaniewska M, Papla I, (2005) Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats. Neuropeptides 39: 525-533. (Pubitemid 41443528)
42. Richter RM, Pich EM, Koob GF, Weiss F, (1995) Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 187: 169-172.
43. Richter RM, Weiss F, (1999) In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32: 254-261. (Pubitemid 29222639)
44. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ, (2002) Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci U S A 99: 13908-13913. (Pubitemid 35215479)
45. Rudoy CA, Reyes AR, Van Bockstaele EJ, (2009) Evidence for beta1-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal. Neuropsychopharmacology 34: 1135-1148.
46. Sajdyk TJ, Gehlert DR, (2000) Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala. Brain Res 877: 226-234.
47. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A, (1999) Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 100: 207-215. (Pubitemid 29130255)
48. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G, (1993) Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats. Brain Res 616: 315-319. (Pubitemid 23200062)
49. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G, (1995) Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res 675: 89-97.
50. Sarnyai Z, Hohn J, Szabo G, Penke B, (1992) Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci 51: 2019-2024.
51. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J, (1998) CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) 137: 184-190. (Pubitemid 28227336)
52. Skelton KH, Nemeroff CB, Knight DL, Owens MJ, (2000) Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci 20: 1240-1248. (Pubitemid 30220480)
53. Specio SE, Wee S, O'Dell LE, Boutrel B, Zorrilla EP, Koob GF, (2008) CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl) 196: 473-482. (Pubitemid 351191180)
54. Valentino RJ, Liouterman L, Van Bockstaele EJ, (2001) Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J Comp Neurol 435: 450-463. (Pubitemid 32574296)
55. Van PK, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE, (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212.
56. Waselus M, Nazzaro C, Valentino RJ, Van Bockstaele EJ, (2009) Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol Psychiatry 66: 76-83.
57. Wee S, Specio SE, Koob GF, (2007) Effects of dose and session duration on cocaine self-administration in rats. J Pharmacol Exp Ther 320: 1134-1143. (Pubitemid 46294040)
58. Zhou Y, Spangler R, Ho A, Kreek MJ, (2003) Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine. Brain Res Mol Brain Res 114: 73-79. (Pubitemid 36627998)
59. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ, (1996) Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"- pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 279: 351-358.
60. Zorrilla EP, Koob GF, (2004) The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13: 799-828. (Pubitemid 39028932)
61. Zorrilla EP, Valdez GR, Weiss F, (2001) Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158: 374-381. (Pubitemid 33141313)